Teva Pharmaceutical Industries Misses Q1 Earnings Estimates Maintains Forecast for 2023 - Best Stocks
Teva (TEVA) to Report Q4 Earnings: What's in the Cards?
TEVA Stock Up on Q4 Earnings Beat, Sales Miss Estimates | Nasdaq
Teva Pharmaceutical Stock Dives Despite a Better-Than-Expected Earnings Report | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Teva Pharmaceutical falls 6% on eve of Q3 earnings show | Seeking Alpha
Teva Pharmaceuticals Stock Jumps After Reporting Earnings. What You Need to Know. | Barron's
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Israel's TEVA, PERI Tank on Q4 Earnings; IZRL in Focus - TipRanks.com
TEVA Plunges on Q1 Results - TipRanks.com
Teva Earnings: Is It Time to Worry? | Barron's
Teva Pharmaceutical Industries Third Quarter 2022 Earnings: Misses Expectations
Teva Q2 Earnings: 5 Reasons Why Shares Rose By 30% (NYSE:TEVA) | Seeking Alpha
Q3 pharma earnings roundup: Moderna, Regeneron and Teva
TEVA Stock Price and Chart — TASE:TEVA — TradingView
Teva taps new CFO, hikes legal set-aside to more than $1B as opioid deal falters | Fierce Pharma
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Five Considerations After Teva Pharmaceuticals' Q3 Report (NYSE:TEVA) | Seeking Alpha
Teva reports jump in first-quarter earnings, raises guidance | The Times of Israel
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results | AlphaStreet
Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
